Metastron and malignant pleural effusion Patient Reports February 13, 2012

Metastron Side Effects Report #5909591-2
Metastron side effect was reported by a Consumer or non-health professional from JAPAN on Sept 22, 2008. Male patient, 60 years of age, weighting 167.6 lb, was diagnosed with metastatic pain and was treated with Metastron. After drug was administered, patient experienced the following side effects: condition aggravated, malignant pleural effusion, pneumonia . Metastron dosage: unknown. Patient died on 08/02/2008.

Metastron Side Effects Report #6062356-6
Metastron side effect was reported by a Physician from JAPAN on Jan 22, 2009. Male patient, 60 years of age, weighting 167.6 lb, was diagnosed with metastatic pain and was treated with Metastron. After drug was administered, patient experienced the following side effects: condition aggravated, malignant pleural effusion, platelet count decreased, pneumonia . Metastron dosage: unknown. Patient recovered.

Metastron Side Effects Report #5945979-1
Metastron side effect was reported by a Consumer or non-health professional from JAPAN on Oct 29, 2008. Male patient, 57 years of age, weighting 106.9 lb, was diagnosed with metastatic pain and was treated with Metastron. After drug was administered, patient experienced the following side effects: condition aggravated, malignant pleural effusion. Metastron dosage: 2.6 ML, SINGLE DOSE, I.V.. Patient died on 08/02/2008.

Metastron Side Effects Report #6062378-5
Metastron side effect was reported by a Physician from JAPAN on Jan 22, 2009. Male patient, 57 years of age, weighting 106.9 lb, was diagnosed with metastases to bone, metastatic pain and was treated with Metastron. After drug was administered, patient experienced the following side effects: condition aggravated, malignant pleural effusion. Metastron dosage: unknown. Patient recovered.


Metastron Side Effects Report #5753003-9
Metastron side effect was reported by a Consumer or non-health professional from JAPAN on May 16, 2008. Male patient, 36 years of age, was treated with Metastron. After drug was administered, patient experienced the following side effects: malignant pleural effusion. Metastron dosage: unknown. Patient died on 05/10/2008.